key challenges in immunotherapy for aml
Published 1 year ago • 195 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
2:15
challenges with immunotherapy in aml: target antigen selection, t-cell exhaustion and more
-
2:05
challenges with immunotherapy in aml: on-target, off-tumor toxicity
-
11:19
immunotherapy for aml & all
-
6:38
unmet needs and key challenges in the treatment of all
-
2:48
key targets and the future of immunotherapy in aml
-
1:07
challenges in treating aml
-
1:46
challenges in utilizing mutation testing in aml
-
2:17
key challenges in treating patients with t(11;14) multiple myeloma with bcl2 inhibitors
-
4:41
acute myeloid leukemia survival rate and outlook
-
4:48
understanding acute myeloid leukemia - part 1
-
7:46
updates in aml treatment and research from asco 2023
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
2:16
the challenges in producing efficacious i-o products for aml
-
0:53
challenges with bringing novel immune therapies to mds
-
14:23
highlights from day 2: addressing challenges in car-t therapy for all, aml, cll & more…
-
1:24
exciting immunotherapy clinical trials for the management of aml
-
1:11
adoptive cellular therapy in aml: challenges and different approaches
-
4:14
key challenges in hemophilia management and diagnosis in resource-constrained countries
-
1:48
the challenges of choosing the right target antigen in aml compared to all
-
1:35
an overview of the main challenges to prolonging remission in aml
-
1:17
integrating car-t in community-based practices across b-cell lymphomas: key challenges
-
1:14
promising novel agents in aml: menin inhibitors